Tofts P S, du Boulay E P
Multiple Sclerosis NMR Research Group, Institute of Neurology, London, England.
Neuroradiology. 1990;32(5):407-15. doi: 10.1007/BF00588474.
The nature and physical significance of the relaxation times T1 and T2 and of proton density are described. Methods of measuring T1 and T2 are discussed with emphasis on the establishment of precision and the maintenance of accuracy. Reported standards of success are briefly reviewed. We expect sensitivities of the order of 1% to be achievable in serial studies. Although early hopes of disease diagnosis by tissue characterisation were not realised, strict scientific method and careful calibration have made it practicable to apply relaxation time measurement to research into disease process. Serial measurements in patients and correlation with similar studies in animal models, biopsy results and autopsy material taken together have provided new knowledge about cerebral oedema, water compartmentation, alcoholism and the natural history of multiple sclerosis. There are prospects of using measurement to monitor treatment in other diseases with diffuse brain abnormalities invisible on the usual images. Secondarily derived parameters and notably the quantification of blood-brain barrier defect after injection of Gadolinium-DTPA also offer prospects of valuable data.
文中描述了弛豫时间T1和T2以及质子密度的性质和物理意义。讨论了测量T1和T2的方法,重点在于精度的确立和准确性的维持。简要回顾了已报道的成功标准。我们预计在系列研究中可实现约1%的灵敏度。尽管早期通过组织特征进行疾病诊断的希望未能实现,但严格的科学方法和仔细的校准已使将弛豫时间测量应用于疾病过程研究变得切实可行。对患者进行的系列测量以及与动物模型、活检结果和尸检材料的类似研究相结合,已提供了关于脑水肿、水分分布、酒精中毒和多发性硬化自然史的新知识。在其他具有常规影像上不可见的弥漫性脑异常的疾病中,利用测量来监测治疗具有前景。二次衍生参数,特别是注射钆喷酸葡胺后血脑屏障缺陷的量化,也提供了有价值数据的前景。